Literature DB >> 21971283

Screening: FRAX in clinical practice.

Bo Abrahamsen.   

Abstract

Mesh:

Year:  2011        PMID: 21971283     DOI: 10.1038/nrrheum.2011.155

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  8 in total

Review 1.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

2.  Time since prior fracture is a risk modifier for 10-year osteoporotic fractures.

Authors:  Lora M Giangregorio; William D Leslie
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

3.  Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.

Authors:  B Abrahamsen; L S Stilgren; A P Hermann; C L Tofteng; O Bärenholdt; P Vestergaard; C Brot; S P Nielsen
Journal:  J Bone Miner Res       Date:  2001-07       Impact factor: 6.741

4.  Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.

Authors:  W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

5.  Effect of osteoporosis treatment on mortality: a meta-analysis.

Authors:  Mark J Bolland; Andrew B Grey; Greg D Gamble; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

6.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

Review 7.  Interpretation and use of FRAX in clinical practice.

Authors:  J A Kanis; D Hans; C Cooper; S Baim; J P Bilezikian; N Binkley; J A Cauley; J E Compston; B Dawson-Hughes; G El-Hajj Fuleihan; H Johansson; W D Leslie; E M Lewiecki; M Luckey; A Oden; S E Papapoulos; C Poiana; R Rizzoli; D A Wahl; E V McCloskey
Journal:  Osteoporos Int       Date:  2011-07-21       Impact factor: 4.507

8.  Zoledronic acid and clinical fractures and mortality after hip fracture.

Authors:  Kenneth W Lyles; Cathleen S Colón-Emeric; Jay S Magaziner; Jonathan D Adachi; Carl F Pieper; Carlos Mautalen; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Kathy A Moore; Catherine Lavecchia; Jie Zhang; Peter Mesenbrink; Patricia K Hodgson; Ken Abrams; John J Orloff; Zebulun Horowitz; Erik Fink Eriksen; Steven Boonen
Journal:  N Engl J Med       Date:  2007-09-17       Impact factor: 91.245

  8 in total
  4 in total

Review 1.  Osteoporosis prevention, screening, and treatment: a review.

Authors:  Juliana M Kling; Bart L Clarke; Nicole P Sandhu
Journal:  J Womens Health (Larchmt)       Date:  2014-04-25       Impact factor: 2.681

Review 2.  Osteoporosis, frailty and fracture: implications for case finding and therapy.

Authors:  Joop P van den Bergh; Tineke A van Geel; Piet P Geusens
Journal:  Nat Rev Rheumatol       Date:  2012-01-17       Impact factor: 20.543

3.  BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women.

Authors:  Zhao Ma; Yong Yang; JiSheng Lin; XiaoDong Zhang; Qian Meng; BingQiang Wang; Qi Fei
Journal:  Clin Interv Aging       Date:  2016-08-04       Impact factor: 4.458

4.  Novel nomogram for predicting the 3-year incidence risk of osteoporosis in a Chinese male population.

Authors:  Yaqian Mao; Lizhen Xu; Ting Xue; Jixing Liang; Wei Lin; Junping Wen; Huibin Huang; Liantao Li; Gang Chen
Journal:  Endocr Connect       Date:  2021-09-13       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.